A phase II study of AT-101 (gossypol) in chemotherapy-sensitive recurrent extensive stage small cell lung cancer (ES-SCLC)

Por Baggstrom, Maria Q., Qi, Yingwei, Koczywas, Marianna, Argiris, Athanassios, Johnson, Elizabeth A., Millward, Michael J., Murphy, Sara C., Erlichman, Charles, Rudin, Charles M., Govindan, Ramaswamy
Publicado em 2011

Phase II study of dasatinib in patients with previously treated malignant mesothelioma (Cancer and Leukemia Group B 30601): a brief report

Por Dudek, Arkadiusz Z., Pang, Herbert, Kratzke, Robert A., Otterson, Gregory A., Hodgson, Lydia, Vokes, Everett E., Kindler, Hedy L.
Publicado em 2012

Sarcomatoid lung carcinomas show high levels of Programmed death Ligand-1 (PD-L1)

Por Velcheti, Vamsidhar, Rimm, David L., Schalper, Kurt A.
Publicado em 2013

E-Cigarettes and Cancer Patients

Por Cummings, K. Michael, Dresler, Carolyn M., Field, John K., Fox, Jesme, Gritz, Ellen R., Hanna, Nasser H., Ikeda, Norihiko, Jassem, Jacek, Mulshine, James L., Peters, Matthew J., Yamaguchi, Nise H., Warren, Graham, Zhou, Caicun
Publicado em 2014

The presence of asbestos in the natural environment is likely related to mesothelioma in young individuals and women from Southern Nevada

Por Baumann, Francine, Buck, Brenda J., Metcalf, Rodney V., McLaurin, Brett T., Merkler, Doug, Carbone, Michele
Publicado no J Thorac Oncol (2015)

The 2015 WHO Classification of Tumors of the Thymus: Continuity and Changes

Por Marx, Alexander, Chan, John K.C., Coindre, Jean-Michel, Detterbeck, Frank, Girard, Nicolas, Harris, Nancy L., Jaffe, Elaine S., Kurrer, Michael O., Marom, Edith M., Moreira, Andre L., Mukai, Kiyoshi, Orazi, Attilio, Ströbel, Philipp
Publicado no J Thorac Oncol (2015)

Non–Small Cell Lung Cancer: Role of the Immune System and Potential for Immunotherapy

Por Carbone, David P., Gandara, David R., Antonia, Scott J., Zielinski, Christoph, Paz-Ares, Luis
Publicado no J Thorac Oncol (2015)

The Utility of Exercise Testing in Patients with Lung Cancer

Por Ha, Duc, Mazzone, Peter J., Ries, Andrew L., Malhotra, Atul, Fuster, Mark
Publicado no J Thorac Oncol (2016)

CYFRA 21-1 as a prognostic and predictive marker in advanced non-small cell lung cancer in a prospective trial: CALGB 150304

Por Edelman, Martin J., Hodgson, Lydia, Rosenblatt, Paula Y., Christenson, Robert H., Vokes, Everett, Wang, Xiaofei, Kratzke, Robert
Publicado no J Thorac Oncol (2012)

Targeting MET in Lung Cancer: Will Expectations Finally Be MET?

Por Drilon, Alexander, Cappuzzo, Federico, Ou, Sai-Hong Ignatius, Camidge, D. Ross
Publicado no J Thorac Oncol (2016)

Targeting Mesothelioma Using an Infectivity Enhanced Survivin-Conditionally Replicative Adenoviruses

Por Zhu, Zeng B., Makhija, Sharmila K., Lu, Baogen, Wang, Minghui, Wang, Shuyi, Takayama, Koichi, Siegal, Gene P., Reynolds, Paul N., Curiel, David T.
Publicado em 2006

Inhibition of Hsp90 leads to cell cycle arrest and apoptosis in human malignant pleural mesothelioma

Por Okamoto, Junichi, Mikami, Iwao, Tominaga, Yuichi, Kuchenbecker, Kristopher M., Lin, Yu-Ching, Bravo, Dawn T., Clement, Genevieve, Yagui-Beltran, Adam, Ray, M. Roshni, Koizumi, Kiyoshi, He, Biao, Jablons, David M.
Publicado em 2008

Induction of E-cadherin in Lung Cancer and Interaction with Growth Suppression by Histone Deacetylase Inhibition

Por Kakihana, Masatoshi, Ohira, Tatsuo, Chan, Daniel, Webster, Robin B., Kato, Harubumi, Drabkin, Harry A., Gemmill, Robert M.
Publicado em 2009

Terameprocol (tetra-O-methyl nordihydroguaiaretic acid), an inhibitor of Sp1-mediated survivin transcription, induces radiosensitization in non-small cell lung carcinoma

Por Sun, Yunguang, Giacalone, Nicholas J., Lu, Bo
Publicado em 2011

Frequency and type of epidermal growth factor receptor mutations in African Americans with non-small cell lung cancer

Por Cote, Michele L., Haddad, Ramsi, Edwards, David J., Atikukke, Govindaraja, Gadgeel, Shirish, Soubani, Ayman O., Lonardo, Fulvio, Bepler, Gerold, Schwartz, Ann G., Ethier, Stephen P.
Publicado em 2011

COMPARISON OF PLATINUM BASED CHEMOTHERAPY IN PATIENTS OLDER AND YOUNGER THAN 70 YEARS OF AGE: AN ANALYSIS OF SOUTHWEST ONCOLOGY GROUP TRIALS 9308 AND 9509

Por Blanchard, Elizabeth M., Moon, James, Hesketh, Paul J., Kelly, Karen, Wozniak, Antoinette J., Crowley, John, Gandara, David
Publicado em 2011

Assessment of Objective Responses Utilizing Volumetric Evaluation in Advanced Thymic Malignancies and Metastatic Non-small Cell Lung Cancer

Por Force, Jeremy, Rajan, Arun, Dombi, Eva, Steinberg, Seth M., Giaccone, Giuseppe
Publicado em 2011

Cigarette smoking associated with lung adenocarcinoma in situ in a large case-control study (SFBALCS)

Por Bracci, Paige M., Sison, Jennette, Hansen, Helen, Walsh, Kyle M., Quesenberry, Charles P., Raz, Dan J., Wrensch, Margaret, Wiencke, John K.
Publicado em 2012

Preclinical rationale for use of the clinically-available multitargeted tyrosine kinase inhibitor crizotinib in ROS1 translocated lung cancer

Por Yasuda, Hiroyuki, de Figueiredo-Pontes, Lorena L., Kobayashi, Susumu, Costa, Daniel B.
Publicado em 2012

Therapy resistant cancer stem cells have differing sensitivity to photon versus proton beam radiation

Por Zhang, Xiaochun, Lin, Steven H., Fang, Bingliang, Gillin, Michael, Mohan, Radhe, Chang, Joe Y.
Publicado em 2013